The Capital Market Authority (CMA) Chairman Mohammed ElKuwaiz said real estate firms now have a larger share in planned initial public offerings (IPO) and the funds raised. Currently, around 55 IPO ...

Stallion India Fluorochemicals IPO Listing: Stallion India Fluorochemicals shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of Stallion India ...

The IPO comes at a time when space stocks are rallying, with names like Rocket Lab USA (NASDAQ:RKLB) and Intuitive Machines (NASDAQ:LUNR) seeing double-digit gains since President Trump's ...

Denta Water and Infra IPO got fully subscribed within minutes of opening for bidding on January 22 in the primary market. Founded in 2016, Denta Water and Infra Solutions Ltd has emerged as one of ...

Goldman Sachs CEO David Solomon pointed out that one of the many use case of AI in banking could be to help with writing financial documents. Goldman Sachs CEO David Solomon said investment banks ...

Company cuts upper valuation guidance to $65 bln from $110 bln Investors balked at long-term sales guidance in IPO prospectus IPO a rare opportunity to buy equity in U.S. LNG exporter Also seen as ...

MANILA, Philippines — E-wallet giant GCash will spend the proceeds from its initial public offering (IPO) on expanding the lending business and speeding up international growth, its top ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia and for certain types of chronic myeloid leukemia. Suzhou-based Ascentage ...

Smithfield Foods Inc. is offering Wall Street a seat at the table for potential growth in its packaged-meats business as the bacon and lunch-meat manufacturer set an estimated market ...

The midpoint of the expected IPO price range would give Smithfield a market cap of nearly $10 billion. Smithfield has applied to list on the Nasdaq under the ticker "SFD." Smithfield Foods ...

[an IPO is] the plan.” Mistral, which Mensch launched in 2023 alongside former researchers from Google’s DeepMind and Meta, is often described as Europe’s answer to U.S. incumbents like OpenAI.

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...